Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Total Current Liabilities (2016 - 2025)

Mimedx's Total Current Liabilities history spans 15 years, with the latest figure at $64.3 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 40.95% year-over-year to $64.3 million; the TTM value through Dec 2025 reached $64.3 million, up 40.95%, while the annual FY2025 figure was $64.3 million, 40.95% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $64.3 million at Mimedx, up from $57.7 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $64.3 million in Q4 2025 and bottomed at $36.6 million in Q1 2022.
  • The 5-year median for Total Current Liabilities is $43.6 million (2022), against an average of $45.6 million.
  • The largest annual shift saw Total Current Liabilities tumbled 33.96% in 2022 before it soared 40.95% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $42.4 million in 2021, then rose by 2.83% to $43.6 million in 2022, then increased by 5.63% to $46.0 million in 2023, then fell by 0.9% to $45.6 million in 2024, then skyrocketed by 40.95% to $64.3 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Total Current Liabilities are $64.3 million (Q4 2025), $57.7 million (Q3 2025), and $50.3 million (Q2 2025).